Search

Search Results
Results 321 - 330 of 492 for breast cancer
  • Wezlana
    Drug - 24 Sep 2026
    Consumer Medicine Information (CMI) about Wezlana intended for persons living in Australia.
  • Tarka
    Drug - 24 Sep 2026
    Consumer Medicine Information (CMI) about Tarka intended for persons living in Australia.
  • Clozaril ODT
    Drug - 24 Sep 2026
    Consumer Medicine Information (CMI) about Clozaril ODT intended for persons living in Australia.
  • Alphaclav Duo Viatris 500/125 and Alphaclav Duo Forte Viatris 875/125
    Drug - 10 Sep 2026
    Consumer Medicine Information (CMI) about Alphaclav Duo Viatris 500/125 and Alphaclav Duo Forte Viatris 875/125 intended for persons living in Australia.
  • Nebivolol Viatris
    Drug - 3 Sep 2026
    Consumer Medicine Information (CMI) about Nebivolol Viatris intended for persons living in Australia.
  • Hysone
    Drug - 2 Sep 2026
    Consumer Medicine Information (CMI) about Hysone intended for persons living in Australia.
  • Hydrocortisone Viatris 4 and 20 (formerly Hydrocortisone Mylan)
    Drug - 2 Sep 2026
    Consumer Medicine Information (CMI) about Hydrocortisone Viatris 4 and 20 (formerly Hydrocortisone Mylan) intended for persons living in Australia.
  • Glucovance
    Drug - 27 Aug 2026
    Consumer Medicine Information (CMI) about Glucovance intended for persons living in Australia.
  • Clozaril
    Drug - 19 Aug 2026
    Consumer Medicine Information (CMI) about Clozaril intended for persons living in Australia.
  • Rifadin Oral
    Drug - 27 Jul 2026
    Consumer Medicine Information (CMI) about Rifadin Oral intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback